A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Cerus Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 75,462 shares of CERS stock, worth $122,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,462
Previous 78,064 3.33%
Holding current value
$122,248
Previous $110,000 8.18%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

SELL
$1.16 - $1.6 $3,018 - $4,163
-2,602 Reduced 3.33%
75,462 $119,000
Q2 2025

Jul 10, 2025

BUY
$1.22 - $1.51 $33,052 - $40,908
27,092 Added 53.15%
78,064 $110,000
Q1 2025

Apr 16, 2025

BUY
$1.39 - $2.15 $48,605 - $75,181
34,968 Added 218.5%
50,972 $70,000
Q4 2024

Mar 17, 2025

BUY
$1.52 - $2.03 $24,326 - $32,488
16,004 New
16,004 $24,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.